Healthcare2 min reading time

Red Queen Bio is using AI to design antibodies for future viruses, WSJ says

The Next Web
Read the full article
Red Queen Bio, backed by OpenAI, has raised $36M to develop AI-designed antibody drugs targeting viruses like bird flu, with clinical trials planned for 2027. The startup aims to rapidly scale biological defenses against future viral threats, including those potentially engineered by AI.

More on this story


More in Healthcare

Healthcare2 min read

Google launches $180 Fitbit Edge with a bigger screen and AI coach

The Next Web
Healthcare5 min read

As US medical debt grows, AI will be used more to collect it

The Guardian
Healthcare5 min read

Healthcare AI's Pilot-To-Production Problem

Forbes